HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paul A Gurbel Selected Research

11-dehydro-thromboxane B2

7/2021First Experience Addressing the Prognostic Utility of Novel Urinary Biomarkers in Patients With COVID-19.
1/2020Effects of vorapaxar on clot characteristics, coagulation, inflammation, and platelet and endothelial function in patients treated with mono- and dual-antiplatelet therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paul A Gurbel Research Topics

Disease

67Hemorrhage
10/2021 - 02/2007
64Acute Coronary Syndrome
08/2022 - 12/2002
55Coronary Artery Disease (Coronary Atherosclerosis)
12/2021 - 01/2003
51Thrombosis (Thrombus)
02/2022 - 02/2003
44Myocardial Infarction
02/2021 - 08/2002
22Stroke (Strokes)
02/2021 - 01/2006
21Cardiovascular Diseases (Cardiovascular Disease)
09/2020 - 04/2005
14Inflammation (Inflammations)
02/2022 - 01/2006
13COVID-19
02/2022 - 01/2020
10Atherosclerosis
01/2021 - 05/2015
8Heart Failure
01/2021 - 01/2002
8Peripheral Arterial Disease
11/2020 - 06/2015
7Ischemia
02/2022 - 01/2006
7ST Elevation Myocardial Infarction
01/2021 - 01/2012
6Ischemic Stroke
10/2019 - 03/2008
5Thrombophilia
02/2022 - 02/2014
5Atrial Fibrillation
10/2021 - 07/2011
5Thromboembolism
01/2018 - 03/2008
4Unstable Angina
11/2012 - 12/2002
3Necrosis
12/2020 - 03/2005
3Diabetes Mellitus
01/2019 - 04/2005
3Pathologic Constriction (Stenosis)
01/2018 - 04/2016
3Infarction (Infarctions)
01/2017 - 10/2002
3Type 2 Diabetes Mellitus (MODY)
12/2016 - 11/2009
3Intracranial Hemorrhages (Intracranial Hemorrhage)
12/2015 - 10/2011
3Transient Ischemic Attack
06/2015 - 08/2012
3Coronary Disease (Coronary Heart Disease)
01/2013 - 01/2003
2Thrombocytopenia (Thrombopenia)
01/2022 - 08/2018
2Death (Near-Death Experience)
12/2021 - 04/2005
2Venous Thrombosis (Deep-Vein Thrombosis)
10/2021 - 09/2013
2Vascular Diseases (Vascular Disease)
01/2019 - 12/2016
2Hypersensitivity (Allergy)
01/2017 - 09/2011
2Dyslipidemias (Dyslipidemia)
05/2016 - 07/2015
2Dyspnea (Shortness of Breath)
06/2012 - 07/2010
2Chest Pain (Chest Pains)
10/2002 - 08/2002

Drug/Important Bio-Agent (IBA)

85Clopidogrel (Plavix)FDA Link
06/2021 - 02/2003
68Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2022 - 06/2002
19Prasugrel HydrochlorideFDA Link
10/2021 - 03/2008
19Adenosine Diphosphate (ADP)IBA
01/2021 - 06/2002
16TicagrelorIBA
01/2022 - 12/2009
14Pharmaceutical PreparationsIBA
02/2019 - 10/2002
12Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2002
11AnticoagulantsIBA
10/2021 - 07/2011
11ThrombinFDA Link
11/2020 - 05/2006
10FibrinIBA
12/2021 - 05/2006
102'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
01/2020 - 01/2010
7LipidsIBA
06/2018 - 01/2006
7Cytochrome P-450 CYP2C19IBA
03/2016 - 12/2010
7Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
10/2015 - 10/2005
5vorapaxarIBA
01/2020 - 10/2011
5Warfarin (Coumadin)FDA LinkGeneric
10/2018 - 07/2011
5Fibrinolytic Agents (Antithrombotic Agents)IBA
01/2018 - 04/2003
4Platelet Membrane Glycoprotein IIbIBA
08/2022 - 12/2002
4omega-Chloroacetophenone (Mace)IBA
02/2021 - 04/2016
4C-Reactive ProteinIBA
11/2020 - 03/2004
4Glycoproteins (Glycoprotein)IBA
08/2018 - 01/2005
4Phenobarbital (Luminal)FDA Link
01/2018 - 04/2013
4thienopyridineIBA
04/2017 - 12/2006
4Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2016 - 03/2004
3Fibrinogen (Factor I)FDA Link
01/2022 - 01/2021
3Metalloproteases (Metalloproteinases)IBA
01/2021 - 01/2008
3AntibodiesIBA
12/2020 - 07/2015
3Proprotein Convertase 9IBA
06/2018 - 07/2015
3EnzymesIBA
06/2018 - 10/2007
3oxidized low density lipoproteinIBA
01/2018 - 01/2006
3bivalirudin (Angiomax)FDA Link
01/2018 - 02/2009
3Purinergic P2Y Receptor AntagonistsIBA
04/2017 - 03/2010
3Proton Pump InhibitorsIBA
09/2014 - 01/2010
3Eptifibatide (Integrilin)FDA Link
02/2009 - 12/2002
2fibrin fragment D (D-dimer)IBA
01/2022 - 01/2021
211-dehydro-thromboxane B2IBA
07/2021 - 01/2020
2RivaroxabanIBA
01/2020 - 01/2018
2Blood Coagulation Factors (Coagulation Factor)IBA
01/2019 - 10/2007
2Hemoglobins (Hemoglobin)IBA
10/2018 - 06/2016
2CSL112IBA
05/2018 - 08/2015
2Apolipoprotein A-I (Apolipoprotein A1)IBA
05/2018 - 08/2015
26-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
01/2018 - 08/2017
2Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
12/2017 - 05/2010
2LDL Lipoproteins (beta Lipoproteins)IBA
11/2017 - 01/2006
2Biological ProductsIBA
10/2017 - 10/2007
2TabletsIBA
01/2017 - 09/2014
2Genetic Markers (Genetic Marker)IBA
04/2016 - 05/2015
2AntithrombinsIBA
12/2015 - 09/2013
2P-SelectinIBA
04/2015 - 06/2009
2Cilostazol (Pletal)FDA LinkGeneric
01/2015 - 11/2012
2Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
11/2012 - 10/2007
2Paclitaxel (Taxol)FDA LinkGeneric
11/2011 - 04/2005
2Sirolimus (Rapamycin)FDA Link
11/2011 - 12/2006
2Brain Natriuretic Peptide (Natrecor)FDA Link
07/2010 - 01/2002
2MetalsIBA
01/2007 - 04/2005
2Tissue Plasminogen Activator (Alteplase)FDA Link
01/2005 - 04/2003
2TenecteplaseFDA Link
01/2005 - 04/2003

Therapy/Procedure

103Therapeutics
12/2021 - 06/2002
49Percutaneous Coronary Intervention
08/2022 - 01/2006
33Stents
01/2022 - 10/2002
10Secondary Prevention
01/2020 - 08/2012
7Drug-Eluting Stents
01/2020 - 01/2007
6Coronary Artery Bypass (Coronary Artery Bypass Surgery)
11/2018 - 08/2011
3Drug Therapy (Chemotherapy)
10/2020 - 08/2013
2Heart-Assist Devices
11/2018 - 11/2017